@FiercePharma: Slovenia's Krka expects 2012 profits to fall short, but sees 6% sales hike in 2013; plans hiring, new plants. Article | Follow @FiercePharma
> FDA Commissioner Margaret Hamburg clashed with lawmakers on Capitol Hill yesterday, as she called for clearer FDA authority to regulate compounding pharmacies. Report
> Warren Buffett's Berkshire Hathaway ($BRK.B) unloaded 95% of its stake in Johnson & Johnson ($JNJ) in its latest selloff of the stock. Report
> The U.K.'s cost-effectiveness watchdog gave a final rejection to Pierre Fabre's bladder cancer drug Javior. Report
> Sanofi's ($SNY) Israeli unit is shopping for a consumer healthcare company there, aiming for a deal in the "several tens of millions." Report
> Slovenia's Krka saw net profits drop by 3%, but officials expect a 6% increase in sales for 2013, to €1.2 billion ($1.5 billion), and plan new hires and new plants at home and in Russia. Report
@FierceMedDev: As advocates fight to repeal the device tax, we take a detailed look at how the 2.3% charge would work. Special Report | Follow @FierceMedDev
@MarkHFierce: Hansen Medical, maker of the Magellan Surgical Robot, raised $10M in a new offering. More | Follow @MarkHFierce
@DamianFierce: Roche Diagnostics broke ground on the first phase of its $300M Indianapolis expansion. News | Follow @DamianFierce
> Study: CardioDx's test helps guide cardiology decisions. Story
> Report: U.S. government incentives will spur robust infusion pump sales. Item
Biotech News
@FierceBiotech: From FierceBiotechIT.com: PPD secures adaptive trials software as clinical studies evolve. More | Follow @FierceBiotech
@JohnCFierce: After FDA rejection, Bristol-AstraZeneca team wins E.C. OK for diabetes drug dapagliflozin--new hope for SGLT2 drugs. News | Follow @JohnCFierce
@RyanMFierce: 10 trends in diagnostics from FierceBiotech. #1: Companion Dx. Special Report | Follow @RyanMFierce
> Sanofi's new CSO to steer R&D reinvention drive from Cambridge, MA office. Report
> Troubled Tranzyme reports another key clinical trial failure. News
> Upstart Valor launches with plans to develop armed antibody cancer drugs. Article
Pharma Manufacturing News
> Call for counterfeit drug treaty gets group banned from WHO event. Article
> Regeneron invests $80 million in plant, office project. News
> Promega expands with new China plant. Item
> Genzyme manufacturing upgrades again paying off. Story
Vaccines News
@AlisonBFierce: Inovio Pharmaceuticals, a developer of synthetic vaccines, expanded its existing license agreement with UPenn. More | Follow @AlisonBFierce
> FDA: Dynavax's Heplisav effective against hepatitis B. Report
> Meningitis vaccine ruled safe for warm storage. Article
> Takeda sets sights on the vaccine market. More
> GSK's rotavirus vaccine selected for British program. News
> GSK reports lackluster PhIII malaria vaccine data. Story
And Finally... Beta blockers, used to treat high blood pressure, are considered performance-enhancers in professional golf. Report